DUVIKEN Trademark

Trademark Overview


On Wednesday, March 17, 2021, a trademark application was filed for DUVIKEN with the United States Patent and Trademark Office. The USPTO has given the DUVIKEN trademark a serial number of 90585024. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by ITALFARMACO SPA. The DUVIKEN trademark is filed in the Pharmaceutical Products category with the following description:

Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
duviken

General Information


Serial Number90585024
Word MarkDUVIKEN
Filing DateWednesday, March 17, 2021
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6811510
Registration DateTuesday, August 9, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Goods and ServicesBiochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameITALFARMACO SPA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMilano (MI) I-20126
IT

Party NameITALFARMACO SPA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMilano (MI) I-20126
IT

Party NameITALFARMACO SPA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMilano (MI) I-20126
IT

Trademark Events


Event DateEvent Description
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 15, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 10, 2022ASSIGNED TO EXAMINER
Thursday, February 10, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, February 10, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, January 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 26, 2022ASSIGNED TO LIE
Friday, January 21, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, January 16, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, January 16, 2022LETTER OF SUSPENSION E-MAILED
Sunday, January 16, 2022SUSPENSION LETTER WRITTEN
Thursday, December 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 22, 2021NON-FINAL ACTION E-MAILED
Friday, October 22, 2021NON-FINAL ACTION WRITTEN
Monday, October 18, 2021ASSIGNED TO EXAMINER
Thursday, June 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 20, 2021NEW APPLICATION ENTERED IN TRAM